CLPTM1L antibody

Catalog No. ABIN2432859

Product Details anti-CLPTM1L Antibody

Target: CLPTM1L (CLPTM1-Like (CLPTM1L))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This CLPTM1L antibody is un-conjugated

Application: ELISA, Immunohistochemistry (IHC)

Purification: Affinity purification

Immunogen: Synthetic peptide of human CLPTM1L

Isotype: IgG

Application Details

Application Notes: IHC 1:50-1:200

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.7 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Preservative: Sodium azide

Handling Advice: Avoid freeze / thaw cycles.

Storage: -20 °C

Storage Comment: Store at -20°C. Avoid freeze / thaw cycles.

Target Details for CLPTM1L

Target: CLPTM1L (CLPTM1-Like (CLPTM1L))

Alternative Name: CLPTM1L (CLPTM1L Products)

Synonyms: CRR9 antibody, C130052I12Rik antibody, Crr9 antibody, RGD1307896 antibody, C130052I12RIK antibody, CLPTM1 like antibody, CLPTM1-like antibody, cleft lip and palate transmembrane protein 1-like protein antibody, CLPTM1L antibody, clptm1l antibody, LOC100338302 antibody, Clptm1l antibody

Background: Cleft lip and palate transmembrane protein 1-like protein(CLPTM1-like protein), also known ascisplatin resistance-related protein 9(CRR9p), is aproteinthat in humans is encoded by theCLPTM1Lgene.CRR9p is associated withcisplatin-inducedapoptosis.CLPTM1L, which lies within a cancer susceptibility locus on chromosome 5 (5p15.33), has been found to be commonly over-expressed in lung tumors and to confer resistance to apoptosis caused by genotoxic agents in association with up-regulation of the anti-apoptotic protein, Bcl-xL.

NCBI Accession: NP_110409